Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Combined familial hyperlipidemia with adipose tissue dysfunction

The group of combined familial hyperlipidemia with adipose tissue dysfunction includes genes that are active n adipose tissue and responsible for lipid metabolism there.

Systematic

Familial combined Hyperlipemia
Combined familial hyperlipidemia with VLDL overproduction
Combined familial hyperlipidemia with adipose tissue dysfunction
C5AR2
CREB3L3
LEPR
LIPE
PNPLA2
PPARG
USF1
Combined familial hyperlipidemia with dysfunctional LDL clearance
Combined familial hyperlipidemia with dysfunctional VLDL metabolism

References:

1.

Lohmueller KE et al. (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

external link
2.

Nikiforova MN et al. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

external link
3.

Dwight T et al. (2003) Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

external link
4.

Balthasar N et al. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis.

external link
5.

Wisløff U et al. (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity.

external link
6.

Uchida T et al. (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice.

external link
7.

Hansen SK et al. (2005) Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes.

external link
8.

et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

external link
9.

Scott LJ et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.

external link
10.

Zeggini E et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

external link
11.

None (1978) Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.

external link
12.

None (1973) Effects of parabiosis of obese with diabetes and normal mice.

external link
13.

Tartaglia LA et al. (1995) Identification and expression cloning of a leptin receptor, OB-R.

external link
14.

Chua SC et al. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor.

external link
15.

Chen H et al. (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.

external link
16.

Lee GH et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice.

external link
17.

Considine RV et al. (1996) The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations.

external link
18.

None (1996) Reflections on STAT3, STAT5, and STAT6 as fat STATs.

external link
19.

Ghilardi N et al. (1996) Defective STAT signaling by the leptin receptor in diabetic mice.

external link
20.

Chung WK et al. (1996) Mapping of the OB receptor to 1p in a region of nonconserved gene order from mouse and rat to human.

external link
21.

Takaya K et al. (1996) Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats.

external link
22.

Vaisse C et al. (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.

external link
23.

Winick JD et al. (1996) Identification of microsatellite markers linked to the human leptin receptor gene on chromosome 1.

external link
24.

Takaya K et al. (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat.

external link
25.

Chung WK et al. (1996) Genomic structure of the human OB receptor and identification of two novel intronic microsatellites.

external link
26.

Golden PL et al. (1997) Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels.

external link
27.

Gotoda T et al. (1997) Leptin receptor gene variation and obesity: lack of association in a white British male population.

external link
28.

Gloaguen I et al. (1997) Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance.

external link
29.

Clément K et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction.

external link
30.

Sierra-Honigmann MR et al. (1998) Biological action of leptin as an angiogenic factor.

external link
31.

Ducy P et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.

external link
32.

Rosmond R et al. (2000) Hypertension in obesity and the leptin receptor gene locus.

external link
33.

Quinton ND et al. (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women.

external link
34.

Wauters M et al. (2001) Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance.

external link
35.

Yiannakouris N et al. (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability.

external link
36.

Cohen P et al. (2001) Selective deletion of leptin receptor in neurons leads to obesity.

external link
37.

Tian Z et al. (2002) Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation.

external link
38.

Bates SH et al. (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction.

external link
39.

Kaneto H et al. (2004) Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.

external link
40.

Zhang EE et al. (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.

external link
41.

Morton GJ et al. (2005) Leptin action in the forebrain regulates the hindbrain response to satiety signals.

external link
42.

de Luca C et al. (2005) Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes.

external link
43.

Park KS et al. (2006) Polymorphisms in the leptin receptor (LEPR)--putative association with obesity and T2DM.

external link
44.

Raju SV et al. (2006) Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity.

external link
45.

Farooqi IS et al. (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.

external link
46.

Björnholm M et al. (2007) Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function.

external link
47.

Richert L et al. (2007) Bone mass in prepubertal boys is associated with a Gln223Arg amino acid substitution in the leptin receptor.

external link
48.

Morioka T et al. (2007) Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice.

external link
49.

Seo S et al. (2009) Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling.

external link
50.

Sun Q et al. (2010) Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels.

external link
51.

Duggal P et al. (2011) A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children.

external link
52.

Czupryn A et al. (2011) Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice.

external link
53.

Ding L et al. (2012) Endothelial and perivascular cells maintain haematopoietic stem cells.

external link
54.

Marie CS et al. (2012) Leptin protects host cells from Entamoeba histolytica cytotoxicity by a STAT3-dependent mechanism.

external link
55.

Kunisaki Y et al. (2013) Arteriolar niches maintain haematopoietic stem cell quiescence.

external link
56.

Almeida PE et al. (2009) Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis.

external link
57.

Gupta RK et al. (2010) Transcriptional control of preadipocyte determination by Zfp423.

external link
58.

Zhang LJ et al. (2015) Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection.

external link
59.

Sahin E et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise.

external link
60.

Michalik L et al. (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice.

external link
61.

Tarrade A et al. (2001) PPARgamma/RXRalpha heterodimers control human trophoblast invasion.

external link
62.

Rocchi S et al. (2001) A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity.

external link
63.

Rosen ED et al. (2002) C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

external link
64.

Ren D et al. (2002) PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis.

external link
65.

Agarwal AK et al. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.

external link
66.

Hara M et al. (2002) Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene.

external link
67.

Harris SG et al. (2002) Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.

external link
68.

Yun Z et al. (2002) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia.

external link
69.

Cui Y et al. (2002) Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility.

external link
70.

Akiyama TE et al. (2002) Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.

external link
71.

Ge K et al. (2002) Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.

external link
72.

Pawliczak R et al. (2002) 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells.

external link
73.

Ardlie KG et al. (2002) Testing for population subdivision and association in four case-control studies.

external link
74.

Fajas L et al. (2002) E2Fs regulate adipocyte differentiation.

external link
75.

Savage DB et al. (2002) Digenic inheritance of severe insulin resistance in a human pedigree.

external link
76.

Marques AR et al. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

external link
77.

Frederiksen L et al. (2002) Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.

external link
78.

Sewter C et al. (2002) Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes.

external link
79.

Girnun GD et al. (2002) APC-dependent suppression of colon carcinogenesis by PPARgamma.

external link
80.

Heaney AP et al. (2002) Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

external link
81.

Yu S et al. (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

external link
82.

Hegele RA et al. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.

external link
83.

Fajas L et al. (2002) The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation.

external link
84.

Savage DB et al. (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.

external link
85.

Kolehmainen M et al. (2003) Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.

external link
86.

Ameshima S et al. (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.

external link
87.

Welch JS et al. (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

external link
88.

Qi C et al. (2003) Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis.

external link
89.

Nakamichi Y et al. (2003) PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.

external link
90.

Bruemmer D et al. (2003) Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.

external link
91.

Wang C et al. (2003) Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

external link
92.

Saez E et al. (2003) Genetic deficiency in Pparg does not alter development of experimental prostate cancer.

external link
93.

Eriksson J et al. (2003) The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth.

external link
94.

Memisoglu A et al. (2003) Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass.

external link
95.

Rosen ED et al. (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.

external link
96.

Masud S et al. (2003) Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis.

external link
97.

Herzig S et al. (2003) CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma.

external link
98.

Song J et al. (2003) Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy.

external link
99.

Hevener AL et al. (2003) Muscle-specific Pparg deletion causes insulin resistance.

external link
100.

He W et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

external link
101.

Orio F et al. (2003) Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.

external link
102.

Kelly D et al. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

external link
103.

Evans RM et al. (2004) PPARs and the complex journey to obesity.

external link
104.

Akune T et al. (2004) PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

external link
105.

Picard F et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.

external link
106.

Patsouris D et al. (2004) PPARalpha governs glycerol metabolism.

external link
107.

Zhang J et al. (2004) Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity.

external link
108.

Hegele RA et al. (2004) Unbuckling lipodystrophy from insulin resistance and hypertension.

external link
109.

Tsai YS et al. (2004) Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.

external link
110.

Temelkova-Kurktschiev T et al. (2004) Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.

external link
111.

Buzzetti R et al. (2004) The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.

external link
112.

Bulotta A et al. (2005) The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.

external link
113.

Kim KS et al. (2004) Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects.

external link
114.

Guan Y et al. (2005) Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption.

external link
115.

Pascual G et al. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.

external link
116.

Uno K et al. (2006) Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.

external link
117.

Hansen L et al. (2006) The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients.

external link
118.

Florez JC et al. (2007) Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

external link
119.

Monajemi H et al. (2007) Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

external link
120.

Lüdtke A et al. (2007) Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.

external link
121.

Odegaard JI et al. (2007) Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

external link
122.

Wan Y et al. (2007) Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.

external link
123.

Wan Y et al. (2007) PPAR-gamma regulates osteoclastogenesis in mice.

external link
124.

Are A et al. (2008) Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.

external link
125.

Tang W et al. (2008) White fat progenitor cells reside in the adipose vasculature.

external link
126.

Chandra V et al. (2008) Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA.

external link
127.

Choi JH et al. (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

external link
128.

Ryan KK et al. (2011) A role for central nervous system PPAR-γ in the regulation of energy balance.

external link
129.

Lu M et al. (2011) Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.

external link
130.

Choi JH et al. (2011) Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.

external link
131.

Dutchak PA et al. (2012) Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

external link
132.

Jonker JW et al. (2012) A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis.

external link
133.

Cipolletta D et al. (2012) PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells.

external link
134.

Banks AS et al. (2015) An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.

external link
135.

OMIM.ORG article

Omim 601487 external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits